Korro Bio News and Activities

Presence

Korro Bio is a biotechnology company that develops RNA editing medicines for genetic diseases. Its therapies and research programs serve patients, healthcare providers, and pharmaceutical partners.

Korro Bio products and services overview:

RNA editing therapies
Genetic disease treatments
Liver disease therapies
Drug discovery
Research partnerships

Revenue: ~$0 million

Employees: 130

Headquarters: Cambridge, United States (USA)

Korro Bio is one of the...

Korro Bio is a company listed under the stock ticker KRRO (US).

Executives

View the org chart displaying its 16 main executives

Most searched biographies at Korro Bio

Popular executive movements at Korro Bio

Ram Aiyar who was Chief Executive Officer and Director, becomes Chief Executive Officer, Director and Interim Chief Financial Officer (posted on October 8 2025).
Vineet Agarwal, Chief Financial Officer, will leave the company on Oct. 17, 2025 (posted on October 8 2025).

Create your alert
to follow the executive moves at Korro Bio.